Status:
UNKNOWN
Focused Ultrasound for the Treatment of Neuropathic Pain
Lead Sponsor:
Neurological Associates of West Los Angeles
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
A possible treatment approach for neuropathic pain would employ a process designed to promote healthier function of the ventral posteromedial (VPM) and ventral posterolateral (VPL) thalamic nuclei. Th...
Detailed Description
The present open-label study is being undertaken to evaluate focused transcranial ultrasound therapy as an intervention for patients with neuropathic pain. The subjects in this research study will be ...
Eligibility Criteria
Inclusion
- History of neuropathic pain (onset, location, intensity, duration, quality, aggravating factors)
- Confirmation of nervous system injury through imaging or negative or positive sensory signs confined to the corresponding bodily area
- Failure from at least 3 pharmacological treatments (e.g., antidepressants, anticonvulsants, opioids)
- At least 18 years of age
Exclusion
- Subjects unable to give informed consent
- Subjects who would not be able to lay down without excessive movement in a calm environment
- Pregnancy, women who may become pregnant or are breastfeeding
- Subjects with scalp rash or open wounds on the scalp (for example from treatment of squamous cell cancer)
Key Trial Info
Start Date :
June 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04485208
Start Date
June 30 2020
End Date
December 30 2025
Last Update
September 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurological Associates of West LA
Santa Monica, California, United States, 90403